Multiple bills aimed at addressing the impact of pharmacy benefit managers on prescription drug costs have passed out of key committees on Capitol Hill, but employers say measures that would cement the fiduciary responsibility PBMs must hold towards plans and their enrollees remain left out of all the bills in the House and Senate. They are continuing to press lawmakers to add the measures before either chamber votes later this year on PBM reforms and broader drug pricing packages. Meanwhile,...